Implantable Cardioverter Defibrillator (ICD) Devices Market Size, Share and Trends Analysis - Global - 2022-2028 - MedCore - Includes: Single-Chamber ICDs, Dual-Chamber ICDs,
In 2021, the global ICD market was valued at over $3.6 billion and is expected to grow at a CAGR of 4.1% to reach $4.7 billion by 2028.
Our medical market research analyzed ICD companies in over 70 countries and applied a comprehensive methodology to understand market size, unit sales, company market share, and generate accurate forecasts. This report encompasses the market for single-chamber ICDs, dual-chamber ICDs, and subcutaneous ICDs (S-ICDs).
MARKET REPORT DATA TYPES INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
PROCEDURE NUMBERS
The global ICD market procedure numbers include both initial placement and replacement of single-chamber ICDs, dual-chamber ICDs, and S-ICDs. Despite the dip and recovery in 2020 and 2021 due to postponed elective procedures, the total number of ICD procedures is expected to grow at a moderate single-digit rate during the forecast period.
GLOBAL ICD MARKET TRENDS
The cardiac resynchronization therapy (CRT) device market saw an increase in 2021 compared to the previous year. Although CRTs are the costliest device category within the CRM industry, their added benefits over implantable cardioverter defibrillators (ICDs) make them appealing, overcoming the price difference.
GLOBAL ICD MARKET SHARE INSIGHTS
Medtronic, Abbott, and Boston Scientific were the leading players in the global ICD market. In 2021, Medtronic dominated the market with single-chamber and dual-chamber devices and has a long history of being a leading manufacturer in the ICD industry. Medtronic offers a range of pacemakers, including CobaltTM, CromeTM, EveraTMMRI and others.
GLOBAL ICD MARKET SEGMENTATION SUMMARY
Single-chamber ICDs
Dual-chamber ICDs
Subcutaneous ICDs
RESEARCH SCOPE SUMMARY
Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2021
Forecast: 2022-2028
Historical Data: 2018-2021
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?
Experts Only– iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook